红杉人工智能将其药物发现人工智能扩大到防御和公共安全,以发现威胁。 Redwood AI expands its drug discovery AI to defense and public safety for threat detection.

红木AI公司是一家设在温哥华的AI公司,正在探索扩大其药物发现平台在国防和公共安全方面的用途,包括化学危险筛选、未知化合物分析和前体供应链评估。 Redwood AI, a Vancouver-based AI company, is exploring expanded uses for its drug discovery platform in defense and public safety, including chemical hazard screening, unknown compound analysis, and precursor supply chain assessment. AI驱动的系统最初是为药物开发设计的,它利用预测模型和化学合成工具用于威胁探测和应急准备。 Originally designed for pharmaceutical development, the AI-driven system leverages predictive modeling and chemical synthesis tools for applications in threat detection and emergency preparedness. 该公司认为这些新用途是自然延伸,只需要逐步更新,而不是单独系统。 The company sees these new uses as natural extensions requiring only incremental updates, not a separate system. 由于预计到2035年全球国防开支将超过6.3万亿美元,红木正在评估国家安全和医疗对策方面的机会,同时继续将其核心重点放在毒品发现上。 With global defense spending projected to exceed $6.3 trillion by 2035, Redwood is assessing opportunities in national security and medical countermeasures while maintaining its core focus on drug discovery.